Arthrotec is a medicine containing the active ingredient(s) diclofenac + misoprostol. On this page you will find out more about Arthrotec, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: diclofenac + misoprostol
Over 65 years of age?
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Information for medicine and pack size:
Arthrotec multilayer tablet, 60
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
ARTHROTEC 50 is indicated for patients who require a non-steroidal anti-inflammatory drug (NSAID) together with misoprostol. The diclofenac component of ARTHROTEC 50 is indicated for the treatment of osteoarthritis and rheumatoid arthritis. The misoprostol component of ARTHROTEC 50 is indicated for the prophylaxis of NSAID induced gastric and duodenal ulceration. Known risk factors for NSAID induced gastropathy include age in excess of 60 years, a history of peptic ulcer disease, smoking, previous NSAID gastrointestinal intolerance and the presence of a concomitant disease.
Table of characteristics
round, biconvex, white tablets, 10mm diameter, with four As on one side and 'Searle 1411' on the other.
Images are the copyright of the Pharmacy Guild of Australia
|Dosage Form||Tablet, multilayer|
|Route of administration||Oral|
10 tablets: Prescription Only Medicine, or Prescription Animal Remedy
20 tablets: Prescription Only Medicine, or Prescription Animal Remedy
60 tablets: Prescription Only Medicine, or Prescription Animal Remedy
90 tablets: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.
Found 2 results
Arthrotec Tablets - myDr.com.au
Arthrotec Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Arthrotec 50 (diclofenac sodium/misoprostol) information | myVMC
Arthrotec 50 (diclofenac sodium/misoprostol) is used to relieve a patient of symptoms of osteoarthritis and rheumatoid while protecting their stomach.
Read more on myVMC – Virtual Medical Centre website
Found 1 results
Rofecoxib for osteoarthritis | Cochrane
Editor's note: The anti-inflammatory drug rofecoxib (Vioxx) was withdrawn from the market at the end of September 2004 after it was shown that long-term use (greater than 18 months) could increase the risk of heart attack and stroke. Further information is available at www.vioxx.com.
Read more on Cochrane (Australasian Centre) website